Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
Russo A, Migliavacca M, Zanna I, Valerio MR, Latteri MA, Grassi N, Pantuso G, Salerno S, Dardanoni G, Albanese I, La Farina M, Tomasino RM, Gebbia N, Bazan V. Russo A, et al. Among authors: bazan v. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1322-31. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433709
Nm23-H1 expression does not predict clinical survival in colorectal cancer patients.
Dusonchet L, Corsale S, Migliavacca M, Calò V, Bazan V, Amato A, Cammareri P, Totaro MS, Agnese V, Cascio S, La Rocca G, Sisto PS, Dardanoni G, Valerio MR, Grassi N, Latteri S, Cajozzo M, Buscemi M, Castorina S, Morello V, Tomasino RM, Gebbia N, Russo A. Dusonchet L, et al. Among authors: bazan v. Oncol Rep. 2003 Sep-Oct;10(5):1257-63. Oncol Rep. 2003. PMID: 12883690
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.
Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N; TP53-CRC Collaborative Study Group. Russo A, et al. Among authors: bazan v. J Clin Oncol. 2005 Oct 20;23(30):7518-28. doi: 10.1200/JCO.2005.00.471. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172461 Review.
Hereditary ovarian cancer.
Russo A, Calò V, Bruno L, Rizzo S, Bazan V, Di Fede G. Russo A, et al. Among authors: bazan v. Crit Rev Oncol Hematol. 2009 Jan;69(1):28-44. doi: 10.1016/j.critrevonc.2008.06.003. Epub 2008 Jul 24. Crit Rev Oncol Hematol. 2009. PMID: 18656380 Free article. Review.
Male breast cancer.
Ottini L, Palli D, Rizzo S, Federico M, Bazan V, Russo A. Ottini L, et al. Among authors: bazan v. Crit Rev Oncol Hematol. 2010 Feb;73(2):141-55. doi: 10.1016/j.critrevonc.2009.04.003. Epub 2009 May 7. Crit Rev Oncol Hematol. 2010. PMID: 19427229 Review.
268 results